Fourth Quarter 2021 Financial Results

• Total revenues for the fourth quarter of 2021 were $7,531,000, compared to $1,340,000 in the third quarter of 2021, and $1,971,000 in the fourth quarter of 2020. The increase is attributed mostly to the consolidation of Essemtec, which we purchased in November 2021, and contributed to the revenues.

• Research and development (R&D) expenses for the fourth quarter of 2021 were $15,099,000, compared to $13,726,000 in the third quarter of 2021, and $3,725,000 in the fourth quarter of 2020. The increase resulted primarily from an increase in payroll and related expenses due to more research and development resources, as well as an increase in share-based payments expenses.

• Sales and marketing (S&M) expenses for the fourth quarter of 2021 were $7,690,000, compared to $6,301,000 in the third quarter of 2021, and $2,373,000 in the fourth quarter of 2020. The increase resulted primarily from an increase in payroll and related expenses. During 2021, we decided to invest resources in sales and marketing activities, thus we increased the number of our sales and marketing personnel.

• General and administrative (G&A) expenses for the fourth quarter of 2021 were $6,470,000, compared to $4,843,000 in the third quarter of 2021, and $3,539,000 in the fourth quarter of 2020. The increase resulted primarily from increase in professional services such as legal and accounting.

• Impairment losses for the fourth quarter of 2021 were $140,290,000. During 2021, there was a decline in our share price, such that as of December 31, 2021, the fair value of the Company, which is based on the share price, is lower than its book value of equity. Hence, the Company checked the value of our CGUs to which goodwill is allocated. Given the recoverable amount of the said CGUs, determined on the basis of the value in use of the units, the goodwill, intangibles and property, plant and equipment relating to the groups of the said cash-generating units was reduced by approximately $140 million.

• Net loss for the fourth quarter of 2021 was $159,624,000, or $0.62 per share, compared to $18,237,000, or $0.07 per share, in the third quarter of 2021, and $17,439,000, or $0.20 per share, in the fourth quarter of 2020.

Year Ended December 31 ^st , 2021 Financial Results

• Total revenues for the year ended December 31, 2021, were $10,493,000, compared to $3,399,000 in the year ended December 31, 2020. The increase is attributed mostly to the consolidation of Essemtec, which we purchased in November 2021, and contributed to the revenues.

• R&D expenses for the year ended December 31, 2021, were $41,686,000, compared to $9,878,000 in the year ended December 31, 2020. The increase resulted primarily from an increase in payroll and related expenses due to more research and development resources, as well as an increase in share-based payments expenses.

• S&M expenses for the year ended December 31, 2021, were $22,713,000, compared to $6,597,000 in the year ended December 31, 2020. The increase resulted primarily from an increase in payroll and related expenses. During 2021, we decided to invest increased resources in sales and marketing activities, thus we increased the number of our sales and marketing personnel.

• G&A expenses for the year ended December 31, 2021, were $19,644,000, compared to $20,287,000 in the year ended December 31, 2020. The increase resulted primarily from an increase in payroll and related expenses and increase in professional services such as legal and accounting.

• Impairment losses for the year ended December 31, 2021, were $140,290,000. During 2021, there was a decline in our share price, such that as of December 31, 2021, the fair value of the Company, which is based on the share price, is lower than its book value of equity. Hence, the Company checked the value of our CGUs to which goodwill is allocated. Given the recoverable amount of the said CGUs, determined on the basis of the value in use of the units, the goodwill, intangibles and property, plant and equipment relating to the groups of the said cash-generating units was reduced by approximately $140 million.

• Net loss for the year ended December 31, 2021, was $200,777,000, or $0.81 per share, compared to $48,494,000 or $1.13 per share, in the year ended December 31, 2020.

Balance Sheet Highlights

• Cash and cash equivalents, together with short and long-term bank deposits, totaled $1,355,595,000 as of December 31, 2021, compared to $670,934,000 as of December 31, 2020. The increase compared to December 31, 2020, mainly reflects proceeds received from the sale of American Depositary Shares representing the Company’s ordinary shares, less cash used in operations and investing activities, during the year ended December 31, 2021.

• Total equity totaled $1,344,231,000 as of December 31, 2021, compared to $667,116,000 as of December 31, 2020.

Conference call information

The Company will host a conference call to discuss these financial results today, March 31, 2021, at 9:00 a.m. EDT (4:00 p.m. IDT). U.S. Dial-in Number: 1-866-744-5399, Israel Dial-in Number: 972-3-9180692. Webcast link: https://veidan.activetrail.biz/nanodimensionq4-2021. Please request the “Nano Dimension NNDM call” when prompted by the conference call operator. For those unable to participate in the conference call, there will be a replay available from a link on Nano Dimension’s website at investors.nano-di.com/events-and- presentations.

About Nano Dimension

Nano Dimension’s (Nasdaq: NNDM) vision is to transform the electronics and similar additive manufacturing sectors through the development and delivery of environmentally friendly and economically efficient additive manufacturing, Industry 4.0 solution, while enabling a one-production-step-conversion of digital designs into functioning devices - on-demand, anytime, anywhere.

Nano Dimension plans to execute on this vision by building an eco-friendly and intelligent distributed network of additively manufacturing self-learning & self-improving systems, which are designed to deliver a superior ROI to their owners as well as to Nano Dimension shareholders and stakeholders.

The DragonFly IV ^® system serves cross-industry High- Performance Electronic Device s ( Hi-PEDs ^®) fabrication needs, by depositing proprietary conductive and dielectric materials simultaneously, while concurrently integrating in-situ capacitors, antennas, coils, transformers, and electromechanical components. The outcomes are Hi-PEDs ^® which are integral enablers of autonomous intelligent drones, cars, satellites, smartphones, and in vivo medical devices. These products enable iterative development, IP safety, fast time-to-market, and device performance gains. With DragonFly IV^®, a revolution happens at the click of a button, allowing customers to go from CAD to a functional device in a matter of hours instead of weeks; creating products with better performance; reducing the size and weight of electronic parts and devices; enabling innovation; and, critically important, protecting IP, all the while limiting environmental pollution and chemical waste.

Nano Dimension’s Fabrica 2.0 micro additive manufacturing system enables the production of microparts based on a Digital Light Processor (DLP) engine that achieves repeatable micron levels resolution. The Fabrica 2.0 is engineered with a patented array of sensors that allows a closed feedback loop, using proprietary materials to achieve very high accuracy while remaining a cost-effective mass manufacturing solution. It is used in the areas of micron-level resolution of medical devices, micro-optics, semi-conductors, micro-electronics, micro-electro-mechanical systems (MEMS), microfluidics, and life sciences instruments.